Belleza, Marlou S.

HRN: 29-39-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2026
CEFTRIAXONE 1G (VIAL)
07/30/2026
08/06/2026
IV
2G
OD
Typhoid Fever
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: